COVID-19 Acute Respiratory Distress Syndrome: One Pathogen, Multiple Phenotypes
- PMID: 35667740
- PMCID: PMC9671407
- DOI: 10.1016/j.ccc.2022.02.001
COVID-19 Acute Respiratory Distress Syndrome: One Pathogen, Multiple Phenotypes
Abstract
Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome arising from multiple causes with a range of clinical severity. In recent years, the potential for prognostic and predictive enrichment of clinical trials has been increased with identification of more biologically homogeneous subgroups or phenotypes within ARDS. COVID-19 ARDS also exhibits significant clinical heterogeneity despite a single causative agent. In this review the authors summarize the existing literature on COVID-19 ARDS phenotypes, including physiologic, clinical, and biological subgroups as well as the implications for improving both prognostication and precision therapy.
Keywords: ARDS; COVID-19; Phenotypes; Subtypes.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure S. Empson has no conflict of interest to declare. A.J. Rogers is a pulmonary clinical trials advisor for Merck, not relevant to this work. J.G. Wilson has no conflict of interest to declare.
Figures
References
-
- WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int Available at: Accessed October 1, 2021.
-
- ARDS Definition Task Force, Ranieri V.M., Rubenfeld G.D., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–2533. - PubMed
-
- Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–1308. - PubMed
-
- Papazian L., Forel J.M., Gacouin A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107–1116. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
